<DOC>
	<DOCNO>NCT00797316</DOCNO>
	<brief_summary>The purpose study evaluate blood pressure lower effect safety aliskiren combination Hydrochlorothiazide ( HCTZ ) compare aliskiren monotherapy give metabolic syndrome patient stage 2 systolic hypertension ( mean sit systolic blood pressure [ msSBP ] ≥ 160 mm Hg &lt; 200 mm Hg ) .</brief_summary>
	<brief_title>Aliskiren Plus HCTZ Compared Aliskiren Metabolic Syndrome Patients With Stage 2 Systolic Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Patients eligible able participate study , give write informed consent assessment perform . Male female outpatient ≥ 18 year old . Patients stage 2 systolic hypertension . Patients must msSBP ≥160 mmHg &lt; 200 mmHg Study Visit 5 ( randomization ) . Patients stage 2 systolic hypertension meet least 2 additional component metabolic syndrome define National *Cholesterol Education program ( NCEP ) criterion : Abdominal obesity ( waist circumference &gt; 102 cm men &gt; 88 cm woman ) Current triglycerides ≥ 150 mg/dL medical treatment condition . Current HDL Cholesterol &lt; 40 mg/dL men &lt; 50 mg/dL woman medical treatment condition . Fasting glucose &gt; 100 mg/dL &lt; 126 mg/dL Office blood pressure measure cuff ( msDBP ≥ 110 mmHg msSBP ≥ 200 mmHg ) visit . Use investigational drug time enrollment , within 30 day 5 halflives enrollment , whichever longer . Use aliskiren and/or fix dose combination aliskiren HCTZ participation clinical trial aliskiren and/or aliskiren HCTZ treatment within 30 day Visit 1 . History hypersensitivity medication drug belong similar therapeutic class ( diuretic renin inhibitor ) study drug . History evidence secondary form hypertension . Refractory hypertension , define unresponsive triple drug therapy maximum dose drug , one must diuretic , blood pressure goal ( 140/90mmHg ) . Therapy fix dose combination two active substance represent two drug . Patients 4 antihypertensive medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>aliskiren</keyword>
	<keyword>hydrochlorothiazide</keyword>
	<keyword>systolic blood pressure</keyword>
	<keyword>diastolic blood pressure</keyword>
	<keyword>stage 2</keyword>
</DOC>